Skip to main content

Cura Unveils First-of-Its-Kind Peptide Hair Growth Serum Manufactured at Scale in the United States

By: Get News
Cura Unveils First-of-Its-Kind Peptide Hair Growth Serum Manufactured at Scale in the United States
Breakthrough discovery in peptide science finally enables a consumer-ready formulation

Cura, a biotechnology-driven wellness company, today announced the launch of its Peptide Hair Growth Serum, the first consumer product derived from a newly discovered class of bioactive peptides developed within its U.S. research program. The announcement marks a milestone in the translation of peptide-based scalp health research into large-scale consumer manufacturing.

Over the past two years, Cura’s research division has focused on isolating short-chain peptide sequences capable of signaling follicular regeneration pathways. The discovery led to a proprietary blend of synthetic growth-factor analogues that can be stably produced and incorporated into a topical formulation. While similar peptides have appeared in early academic literature, Cura is the first company to manufacture these compounds at scale and introduce them in a consumer product.

“Peptide-based solutions represent a new frontier for non-invasive hair and scalp support,” said Dr. Eliza Harper, Chief Scientific Officer at Cura. “Our team’s work centered on identifying messenger peptides that mimic the body’s natural signaling mechanisms. By developing the infrastructure to synthesize and stabilize them domestically, we’ve made it possible to deliver research-grade ingredients in a safe, consumer-ready format.”

Each batch of Cura’s peptide serum is produced in GMP-certified U.S. facilities to ensure purity, sequence integrity, and bioavailability. The serum combines five core peptides, including sh-Polypeptide-1 and sh-Oligopeptide-10, with botanical co-factors known to support hair growth and prevent loss.

In a controlled internal study of 120 participants, Cura reported visible improvement in hair density and thickness, with 95% of users experiencing measurable regrowth within 90 days and an average 23% increase in hair count per square centimeter compared to baseline. Participants also noted improved pigmentation and reduced shedding across the study period.

Cura’s internal laboratory data indicate the formulation remains stable for over twelve months and maintains over 95 % peptide activity under controlled storage conditions. The company reports that consumer trials are underway to observe improvements in the appearance of hair fullness, texture, and scalp vitality over an eight-week period.

Beyond the immediate application, Cura views the new platform as a foundation for additional research into regenerative peptide therapeutics for skin and follicle biology.

“Our mission is to bridge the gap between laboratory innovation and accessible wellness technology,” Dr. Harper added. “By controlling every step—from peptide design to synthesis and formulation—we can move responsibly and transparently as this field evolves.”

The Peptide Hair Growth Serum is available through Cura’s official website.

About Cura

Cura is a biotechnology-based consumer health company headquartered in the United States. The company specializes in the discovery, synthesis, and formulation of proprietary peptide technologies that support skin, hair, and cellular wellness. All Cura products are developed and manufactured domestically under GMP standards to ensure consistency, quality, and traceability.

Media Contact

Cura Email: press@curasupps.com

Website: https://curasupps.com

Media Contact
Company Name: Cura
Contact Person: Ryan Sackler
Email: Send Email
Country: United States
Website: https://curasupps.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.